Warby Parker Inc. (WRBY) Fair Value 2026

WRBY · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.6 /10

32 fundamental signals · 7 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-08-28, Warby Parker Inc. (WRBY) trades at $25.00, versus a $7.17 median fair value across its 7 active models — 71.3% below the current price. QOC: 7.6/10. Value Trap Risk: 12/100 (SAFE). 7/13 models active. Within that set, the Bayesian DCF component alone returns $3.79.

Key Facts

Ticker
WRBY
Price
$25.00
Quality Score
7.6/10
Value Trap Risk
12/100
Models Active
7/13
Last Updated
Strength: 7 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Warby Parker Inc. (WRBY) Undervalued or Overvalued in 2026?

According to CirclFi’s 7-model valuation engine, Warby Parker Inc. (WRBY) appears overvalued as of : the median of 7 independent fair value estimates is $7.17, 71.3% below the current price of $25.00. Estimates range from $3.35 to $21.60. WRBY scores 7.6/10 on fundamental quality and 12/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. WRBY’s -71.3% gap is wider than that market norm, and the Medical Instruments & Supplies sector median is -29.3%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Warby Parker Inc. Stock in 2026? →

What Fair Value Does Each Model Give WRBY?

7 Intrinsic Value Models vs. Current Price ($25.00)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $3.79 -84.9%
Ensemble · Low Conviction
 $6.64 -73.5%
Scenario · High Conviction
 $8.45 -66.2%
Unlock the Full Matrix

Access 4 additional models including Regime Cross-Sectional, Sentiment SOTP, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 7 Models →

Cancel anytime · No contracts · Instant access

What Is WRBY's Fair Value Range?

Spread across 7 independent models · $3.35 to $21.60

CirclFi's 7 active models place Warby Parker Inc. (WRBY) between $3.35 and $21.60 per share, a spread of 255% of the median. The median of that range — $7.17 — is the fair value CirclFi publishes for WRBY, against a current price of $25.00.

Low · RCMH-DCFHigh · Regime Cross
$3.35median $7.17$21.60
Where the range comes from
Most bearish modelRCMH-DCF$3.35
Most bullish modelRegime Cross-Sectional$21.60
Model agreement0 bullish · 7 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for WRBY. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on WRBY, not a CirclFi price target. How each model works →

What Is Warby Parker Inc. (WRBY) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Warby Parker Inc.'s intrinsic value is estimated at $7.17. Trading at its current price of $25.00, the valuation engine raises significant caution: 7 of 7 models flag downside risk, projecting a median implied return of -71.3%. The most optimistic model, Regime Cross, places fair value at $21.60 (-13.6%), while RCMH-DCF — the most conservative — estimates $3.35 (-86.6%). This +73.0% gap reflects genuine analytical uncertainty about Warby Parker Inc.'s intrinsic worth.

What Do the Models Say About WRBY?

7 of 13 models are currently active for WRBY. All 7 active models suggest the stock trades above fair value. Taken together, their median fair value for WRBY is $7.17 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $3.79 on its own, implying -84.9% downside from the current price. See which stocks rank higher →

How Does WRBY Rank in Medical Instruments & Supplies?

Among 56 Medical Instruments & Supplies stocks, WRBY ranks #19 by Quality of Company score. CirclFi's QOC score of 7.6/10 evaluates 32 fundamental signals. A score of 7.6 indicates above-average quality.

See all Most Undervalued Medical Instruments & Supplies Stocks →

Warby Parker Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is WRBY a Value Trap?

CirclFi's Value Trap algorithm assigns WRBY a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

7 of 13 models are active for Warby Parker Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Warby Parker Inc. scores 7.6 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +73.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every WRBY valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across WRBY's 7 active models, average confidence is 42%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Warby Parker Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

11 related Medical Instruments & Supplies stocks with 13-model coverage

MDLNMedline Inc.QOC 7.7ICUIICU Medical, Inc.QOC 7.5STVNStevanato Group S.p.A.QOC 7.7SOLVSolventum CorporationQOC 7.2ATRCAtriCure, Inc.QOC 7.8AZTAAzenta, Inc.QOC 7.2BLCOBausch + Lomb CorporationQOC 6.3ZTEKZentek Ltd.QOC 5.4MMSIMerit Medical Systems, Inc.QOC 8.7ISRGIntuitive Surgical, Inc.QOC 9.4RMDResMed Inc.QOC 9.4

Read investment analysis: MDLN · ICUI · STVN · SOLV · ATRC · AZTA · BLCO · ZTEK · MMSI · ISRG · RMD

Which Other Stocks Have a Similar Quality Score to WRBY?

7 companies across all industries closest to WRBY’s Quality of Company score of 7.6/10.

DKDelek US Holdings, Inc.QOC 7.6SUISun Communities, Inc.QOC 7.6RMRegional Management Corp.QOC 7.6NPNeptune Insurance Holdings Inc.QOC 7.6FERFerrovial N.V.QOC 7.6JCAPJefferson Capital, Inc.QOC 7.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: DK · SUI · RM · NP · FER · JCAP · NVDA

Where Does WRBY Sit in CirclFi's Medical Instruments & Supplies Rankings?

WRBY is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About Warby Parker Inc.’s Valuation?

What is Warby Parker Inc.'s intrinsic value in 2026?

CirclFi puts Warby Parker Inc. (WRBY)'s intrinsic value at $7.17 — the median of 7 independent model estimates as of 2026-08-28, ranging from $3.35 to $21.60. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $3.79 on its own. The Quality of Company score is 7.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is WRBY overvalued or undervalued right now?

At $25.00, 0 of 7 active models suggest WRBY may be undervalued, while 7 indicate potential overvaluation. The median of all 7 fair value estimates is $7.17, 71.3% below the current price of $25.00 — a consensus view that WRBY is overvalued. The assessment depends on which methodology best fits Warby Parker Inc.'s business model in Medical Instruments & Supplies.

What does a Quality of Company score of 7.6 mean for WRBY?

Warby Parker Inc.'s QOC of 7.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on WRBY?

CirclFi analyzes WRBY with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 7 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on WRBY?

Of the 7 models currently active on WRBY, Regime Cross-Sectional is the most bullish at $21.60 per share, and RCMH-DCF is the most bearish at $3.35. CirclFi's published fair value for WRBY is the median of that range, $7.17, not either extreme. The gap between the two ends equals 255% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is WRBY a value trap in 2026?

Warby Parker Inc.'s Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 7-model valuation engine, Warby Parker Inc. (WRBY) has a median fair value of $7.17 — 71.3% below the current price of $25.00 — as of 2026-08-28.” Source: circlfi.com/stock/WRBY/ · Methodology
Primary sources for this WRBY valuation
  • Financial statements: Warby Parker Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001504776) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for WRBY as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 7 mathematical frameworks give you clarity on WRBY.

Unlock All 7 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for WRBY Unlock All 7 — $39/mo